CNOT4 overexpression suppressed tumor growth in vivo and enhanced the effect of anti‐PD‐1 immunotherapy, which was accompanied by increased CD3+ and CD8+ T lymphocyte infiltration and higher interferon‐γ and tumor necrosis factor‐α levels. This evidence concerns the gene CD8A and neoplasm.